Shopping Cart 0
Cart Subtotal
USD 0

Dental Bone Graft Substitutes-Medical Devices Pipeline Assessment, 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Dental Bone Graft Substitutes-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Dental Bone Graft Substitutes-Medical Devices Pipeline Assessment, 2017" provides an overview of Dental Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Dental Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Dental Bone Graft Substitutes under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Dental Bone Graft Substitutes and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Dental Bone Graft Substitutes under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Dental Bone Graft Substitutes Overview 6

3 Products under Development 7

3.1 Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 7

3.2 Dental Bone Graft Substitutes-Pipeline Products by Territory 8

3.3 Dental Bone Graft Substitutes-Pipeline Products by Regulatory Path 9

3.4 Dental Bone Graft Substitutes-Pipeline Products by Estimated Approval Date 10

3.5 Dental Bone Graft Substitutes-Ongoing Clinical Trials 11

4 Dental Bone Graft Substitutes-Pipeline Products under Development by Companies 12

4.1 Dental Bone Graft Substitutes Companies-Pipeline Products by Stage of Development 12

4.2 Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 13

5 Dental Bone Graft Substitutes Companies and Product Overview 14

5.1 3-D Matrix Ltd Company Overview 14

5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 botiss dental GmbH Company Overview 16

5.2.1 botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 curasan AG Company Overview 19

5.3.1 curasan AG Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Maxigen Biotech Inc Company Overview 21

5.4.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Medtronic plc Company Overview 22

5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 NovaBone Products LLC Company Overview 23

5.6.1 NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 PolyPid Ltd Company Overview 24

5.7.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 26

5.8.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 University of Maryland Company Overview 27

5.9.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 27

6 Dental Bone Graft Substitutes- Recent Developments 28

6.1 Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne 28

6.2 Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion 32

6.3 Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million 32

6.4 Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million 33

6.5 Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development 33

6.6 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 34

6.7 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million 37

6.8 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 38

6.9 Jan 31, 2017: Antibe Therapeutics Announces the Launch of PentOS OI Max, its Newest Bone Graft Substitute for Oral and Maxillofacial Surgery 39

6.10 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 39

6.11 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 41

6.12 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 42

6.13 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 45

6.14 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 46

6.15 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter 46

6.16 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 47

6.17 Oct 27, 2016: Stryker reports third quarter 2016 results 49

6.18 Oct 27, 2016: Another Strong Quarter (+13% Organic) Keeps Straumann On Track To Achieve Full-Year Targets 50

6.19 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 53

6.20 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 54

6.21 Aug 23, 2016: Strong Performance Continues As Organic Growth Of 14% Lifts First-Half Revenue To Record Level 57

6.22 Aug 23, 2016: Straumann reports strong performance continues as organic growth of 14% lifts first-half revenue to record level 62

6.23 Aug 18, 2016: curasan accelerates sales growth in the first six months due to rising foreign demand 67

6.24 Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate 68

6.25 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 68

6.26 Jul 21, 2016: Stryker reports second quarter 2016 results 69

6.27 Jul 18, 2016: Straumann takes over distribution of botiss products in Germany 70

6.28 Jul 14, 2016: Straumann to Acquire Controlling Stake in MegaGen 71

6.29 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 71

6.30 Jun 27, 2016: Dentsply Sirona to Acquire MIS Implants Technologies for USD375 Million 71

6.31 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 72

6.32 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 72

6.33 May 23, 2016: Straumann Announces Change In Board Of Directors And Compensation Committee 75

6.34 May 11, 2016: curasan posts sales growth in the first quarter 75

6.35 May 03, 2016: Straumann reports strong start to the year with organic revenue growth of 12% in Q1 76

6.36 Apr 28, 2016: Curasan: Annual results influenced by positive trends in growth regions 78

7 Appendix 79

7.1 Methodology 79

7.2 About GlobalData 82

7.3 Contact Us 82

7.4 Disclaimer 82


List Of Figure

1.2 List of Figures

Figure 1: Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 7

Figure 2: Dental Bone Graft Substitutes-Pipeline Products by Territory 8

Figure 3: Dental Bone Graft Substitutes-Pipeline Products by Regulatory Path 9

Figure 4: Dental Bone Graft Substitutes-Pipeline Products by Estimated Approval Date 10

Figure 5: Dental Bone Graft Substitutes-Ongoing Clinical Trials 11


List Of Table

1.1 List of Tables

Table 1: Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 7

Table 2: Dental Bone Graft Substitutes-Pipeline Products by Territory 8

Table 3: Dental Bone Graft Substitutes-Pipeline Products by Regulatory Path 9

Table 4: Dental Bone Graft Substitutes-Pipeline Products by Estimated Approval Date 10

Table 5: Dental Bone Graft Substitutes-Ongoing Clinical Trials 11

Table 6: Dental Bone Graft Substitutes Companies-Pipeline Products by Stage of Development 12

Table 7: Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 13

Table 8: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: TDM-711-Product Status 14

Table 10: TDM-711-Product Description 15

Table 11: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: maxresorb-Product Status 16

Table 13: maxresorb-Product Description 16

Table 14: maxresorb Inject-Product Status 17

Table 15: maxresorb Inject-Product Description 17

Table 16: perossal-Product Status 17

Table 17: perossal-Product Description 18

Table 18: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 19

Table 19: Cerasorb Foam Dental-Product Status 19

Table 20: Cerasorb Foam Dental-Product Description 20

Table 21: Cerasorb Paste Dental-Product Status 20

Table 22: Cerasorb Paste Dental-Product Description 20

Table 23: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 24: MaxiBone-Product Status 21

Table 25: MaxiBone-Product Description 21

Table 26: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 27: MD05-P Bone Graft Substitute Material-Product Status 22

Table 28: MD05-P Bone Graft Substitute Material-Product Description 22

Table 29: NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Table 30: Bioengineered Resorbable Bone Graft-Dental-Product Status 23

Table 31: Bioengineered Resorbable Bone Graft-Dental-Product Description 23

Table 32: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Table 33: BonyPid-500-Product Status 24

Table 34: BonyPid-500-Product Description 25

Table 35: PolyPid Ltd-Ongoing Clinical Trials Overview 25

Table 36: BonyPid-500-PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute 25

Table 37: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 26

Table 38: BioCaS-Product Status 26

Table 39: BioCaS-Product Description 26

Table 40: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 27

Table 41: Injectable Scaffold-Product Status 27

Table 42: Injectable Scaffold-Product Description 27

Table 43: Glossary 81

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

3-D Matrix Ltd, botiss dental GmbH, curasan AG, Maxigen Biotech Inc, Medtronic plc, NovaBone Products LLC, PolyPid Ltd, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of Maryland

Dental Bone Graft Substitutes-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Dental Bone Graft Substitutes-Medical Devices Pipeline Assessment, 2017" provides an overview of Dental Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Dental Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Dental Bone Graft Substitutes under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Dental Bone Graft Substitutes and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Dental Bone Graft Substitutes under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Dental Bone Graft Substitutes Overview 6

3 Products under Development 7

3.1 Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 7

3.2 Dental Bone Graft Substitutes-Pipeline Products by Territory 8

3.3 Dental Bone Graft Substitutes-Pipeline Products by Regulatory Path 9

3.4 Dental Bone Graft Substitutes-Pipeline Products by Estimated Approval Date 10

3.5 Dental Bone Graft Substitutes-Ongoing Clinical Trials 11

4 Dental Bone Graft Substitutes-Pipeline Products under Development by Companies 12

4.1 Dental Bone Graft Substitutes Companies-Pipeline Products by Stage of Development 12

4.2 Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 13

5 Dental Bone Graft Substitutes Companies and Product Overview 14

5.1 3-D Matrix Ltd Company Overview 14

5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 botiss dental GmbH Company Overview 16

5.2.1 botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 curasan AG Company Overview 19

5.3.1 curasan AG Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Maxigen Biotech Inc Company Overview 21

5.4.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Medtronic plc Company Overview 22

5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 NovaBone Products LLC Company Overview 23

5.6.1 NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 PolyPid Ltd Company Overview 24

5.7.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 26

5.8.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 University of Maryland Company Overview 27

5.9.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 27

6 Dental Bone Graft Substitutes- Recent Developments 28

6.1 Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne 28

6.2 Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion 32

6.3 Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million 32

6.4 Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million 33

6.5 Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development 33

6.6 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 34

6.7 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million 37

6.8 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 38

6.9 Jan 31, 2017: Antibe Therapeutics Announces the Launch of PentOS OI Max, its Newest Bone Graft Substitute for Oral and Maxillofacial Surgery 39

6.10 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 39

6.11 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 41

6.12 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 42

6.13 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 45

6.14 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 46

6.15 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter 46

6.16 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 47

6.17 Oct 27, 2016: Stryker reports third quarter 2016 results 49

6.18 Oct 27, 2016: Another Strong Quarter (+13% Organic) Keeps Straumann On Track To Achieve Full-Year Targets 50

6.19 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 53

6.20 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 54

6.21 Aug 23, 2016: Strong Performance Continues As Organic Growth Of 14% Lifts First-Half Revenue To Record Level 57

6.22 Aug 23, 2016: Straumann reports strong performance continues as organic growth of 14% lifts first-half revenue to record level 62

6.23 Aug 18, 2016: curasan accelerates sales growth in the first six months due to rising foreign demand 67

6.24 Aug 16, 2016: NovaBone Products Receives GMP Medical Device Certificate 68

6.25 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 68

6.26 Jul 21, 2016: Stryker reports second quarter 2016 results 69

6.27 Jul 18, 2016: Straumann takes over distribution of botiss products in Germany 70

6.28 Jul 14, 2016: Straumann to Acquire Controlling Stake in MegaGen 71

6.29 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 71

6.30 Jun 27, 2016: Dentsply Sirona to Acquire MIS Implants Technologies for USD375 Million 71

6.31 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 72

6.32 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 72

6.33 May 23, 2016: Straumann Announces Change In Board Of Directors And Compensation Committee 75

6.34 May 11, 2016: curasan posts sales growth in the first quarter 75

6.35 May 03, 2016: Straumann reports strong start to the year with organic revenue growth of 12% in Q1 76

6.36 Apr 28, 2016: Curasan: Annual results influenced by positive trends in growth regions 78

7 Appendix 79

7.1 Methodology 79

7.2 About GlobalData 82

7.3 Contact Us 82

7.4 Disclaimer 82


List Of Figure

1.2 List of Figures

Figure 1: Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 7

Figure 2: Dental Bone Graft Substitutes-Pipeline Products by Territory 8

Figure 3: Dental Bone Graft Substitutes-Pipeline Products by Regulatory Path 9

Figure 4: Dental Bone Graft Substitutes-Pipeline Products by Estimated Approval Date 10

Figure 5: Dental Bone Graft Substitutes-Ongoing Clinical Trials 11


List Of Table

1.1 List of Tables

Table 1: Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 7

Table 2: Dental Bone Graft Substitutes-Pipeline Products by Territory 8

Table 3: Dental Bone Graft Substitutes-Pipeline Products by Regulatory Path 9

Table 4: Dental Bone Graft Substitutes-Pipeline Products by Estimated Approval Date 10

Table 5: Dental Bone Graft Substitutes-Ongoing Clinical Trials 11

Table 6: Dental Bone Graft Substitutes Companies-Pipeline Products by Stage of Development 12

Table 7: Dental Bone Graft Substitutes-Pipeline Products by Stage of Development 13

Table 8: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: TDM-711-Product Status 14

Table 10: TDM-711-Product Description 15

Table 11: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: maxresorb-Product Status 16

Table 13: maxresorb-Product Description 16

Table 14: maxresorb Inject-Product Status 17

Table 15: maxresorb Inject-Product Description 17

Table 16: perossal-Product Status 17

Table 17: perossal-Product Description 18

Table 18: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 19

Table 19: Cerasorb Foam Dental-Product Status 19

Table 20: Cerasorb Foam Dental-Product Description 20

Table 21: Cerasorb Paste Dental-Product Status 20

Table 22: Cerasorb Paste Dental-Product Description 20

Table 23: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 24: MaxiBone-Product Status 21

Table 25: MaxiBone-Product Description 21

Table 26: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 27: MD05-P Bone Graft Substitute Material-Product Status 22

Table 28: MD05-P Bone Graft Substitute Material-Product Description 22

Table 29: NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Table 30: Bioengineered Resorbable Bone Graft-Dental-Product Status 23

Table 31: Bioengineered Resorbable Bone Graft-Dental-Product Description 23

Table 32: PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Table 33: BonyPid-500-Product Status 24

Table 34: BonyPid-500-Product Description 25

Table 35: PolyPid Ltd-Ongoing Clinical Trials Overview 25

Table 36: BonyPid-500-PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute 25

Table 37: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 26

Table 38: BioCaS-Product Status 26

Table 39: BioCaS-Product Description 26

Table 40: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 27

Table 41: Injectable Scaffold-Product Status 27

Table 42: Injectable Scaffold-Product Description 27

Table 43: Glossary 81

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

3-D Matrix Ltd, botiss dental GmbH, curasan AG, Maxigen Biotech Inc, Medtronic plc, NovaBone Products LLC, PolyPid Ltd, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of Maryland